Osteoporosis is the most common human bone disease, characterized by low bone mass and micro architectural deterioration of bone tissue, leading to bone fragility and an increase in the risk of fracture.

Osteoporosis is disease reaching epidemic proportions in the elderly populations. Currently, an estimated 10 million Americans suffer from osteoporosis and another 18 million more have low bone mass, putting them at risk for the pain and debilitation of fracture 1.5 million each year, including 300.000 hip fractures, 20 % of which lead to death within a year.

Osteoporosis affects an enormous number of people, an it’s prevalence will increase as the populations ages. It is estimated that between 13 % and 18 % of postmenopausal white women in the United States have osteoporosis, and an additional 30 % to 50 % have low bone density at the hip. One out of every two white women will experience an osteoporosis fracture at some point in her lifetime; there is also a significant risk, although a lower one, for nonwhite women and for men.

Fractures and there complications are the relevant clinical sequel of Osteoporosis. The most common fractures are those of the proximal femur (hip), vertebrate (spine), and distal forearm (wrist), but because osteoporosis is a systemic disease causing bone loss throughout the skeleton, almost all fractures in older adults are due in part to low bone density. 

The most serious outcome of osteoporosis is hip fracture, which can result in up to 10 % to 20 % excess mortality within 1 year.

Additionally, up to 25 % of hip fracture patients may require long term nursing home care, and only a third fully regain their pre-fracture level of independence.

Vertebral fracture also cause significant complications including back pain, height loss, and kyphosis. Postural and height changes associated with kyphosis may limit activity, including bending and reaching, and their cosmetic affect may erode self-esteem.

Osteoporosis is preventable and treatable, but because there are now warning signs until fracture occurs, few people are currently being diagnosed in time to receive effective therapy during the disease’s early phase.

The factors associated with an increased risk of osteoporosis fracture can be characterized as modifiable or no modifiable. In general, the more risk factor a woman has, the greater her risk of fracture. If one or more risk factors are present, Bone Mineral Density (BMD) testing may be indicated to determine whether therapy is appropriate.

BMD measurement can be used to establish or confirm a diagnosis of osteoporosis, predict future fracture risk, and monitor changes in BMD due to medical condition or therapy. BMD has a continuous, graded, inverse relationship to the risk of fracture: The lower the BMD, the greater risk.


Osteoporosis Clinic

Jl. Jend. Gatot Subroto Kav. 59 South Jakarta 12950
Phone. 021 - 5210200 Ext. 350 - Fax. 021 - 5210184
email : This e-mail address is being protected from spambots, you need JavaScript enabled to view it




The contents of this webpage are copyright 2007-2008 Medistra Hospital. All rights reserved.